Flexion Therapeutics, Inc (FLXN) Covered Calls

Flexion Therapeutics, Inc covered calls Flexion Therapeutics is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including: anti-inflammatory and analgesic therapies.

You can sell covered calls on Flexion Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for FLXN (prices last updated Fri 4:16 PM ET):

Flexion Therapeutics, Inc (FLXN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
14.96 -0.78 14.01 15.99 363K - 0.0B
Covered Calls For Flexion Therapeutics, Inc (FLXN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 15 0.70 15.29 -1.9% -46.2%
Jan 18 15 1.60 14.39 4.2% 35.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Flexion Therapeutics, Inc. is a pharmaceutical company. The company focused on the development and commercialization of novel, injectable pain therapies. It targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, or OA, a type of degenerative arthritis. The company products include FX006, is a first-in-class injectable, sustained-release, intra-articular, or IA, steroid treatment for patients with moderate to severe OA pain. Flexion Therapeutics was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.